Intended Use
This kit is intended for use as a point-of-care test to quantitatively measure the content of C-reactive Protein (CRP) in human samples (serum, plasma, capillary (fingerstick) whole blood or venipuncture (venous) whole blood) in vitro. Conventional C-reactive protein is clinically suitable for the evaluation of inflammatory response; the common use of high sensitivity C-reactive protein can be used as an auxiliary means for cardiovascular disease risk identification, and used in combination with the traditional clinical diagnosis of acute coronary syndrome, and can be used as an early warning indicator of coronary artery disease or recurrence of acute
